Neutralizing antibodies against the SARS-CoV-2 Omicron variant following two CoronaVac vaccinations and a Pfizer/BioNTech mRNA vaccine booster
Rev. Inst. Med. Trop. São Paulo (Online)
; 64: e43, 2022. tab
Article
in En
|
LILACS-Express
| LILACS
| ID: biblio-1387340
Responsible library:
BR1.1
Full text:
1
Collection:
01-internacional
Database:
LILACS
Language:
En
Journal:
Rev. Inst. Med. Trop. São Paulo (Online)
Journal subject:
Medicina Tropical
Year:
2022
Document type:
Article
/
Project document
Affiliation country:
Country of publication: